Studies have shown that from a quarter to one half of the patients attending general practitioners actually suffering from Somatoform Disorders.
Rer: Court C.Report urges better psychological care. BMJ 1995:310:1027.


The DSM IV describes 5 subtypes of Somatoform disorders
1 Body dysmorphic disorders
2 Pain disorders
3 Hypochondriasis
4 Conversion disorders


And the most common
5 SOMATIZATION DISORDERS
WITH FOLLOWING SYMPTOMS

GIT Symptoms: Nausea, Vomiting Abdominal Pain Heart Burns Gas, Glatulence Diarrhoea	Sexual Symptoms: Burning sensation in sexual organs Pain during intercourse Impotency	Genitourinary Symptoms: Urinary retention or difficulty in urinating. increased frequency of urination.
Pseudoneurological Symptoms: Amnesia Blurred vision Difficulty in swallowing Muscle weekness or fatugue	Cadiopulmonary Symptoms: Shortness of breath Palpitation Chest Pain	Pain Symptoms: Pain of extremities Back Pain Joint Pain Other Pains

The only psychotropic drug indicated to the treatment of somatoform disorders

Variation in the number of SD symptoms with levo-sulpiride or placebo, before and after cross-over (p<0.007). Trial Setup: No.of patients:74 Dose: 50 mg b.i.d.Result: Levopraid 50 has proved a significantly better efficacy compared with placebo in reducing the number & severity of somatoform disorder symptoms.

LEVOPRAID 50 Acts Faster Than Amitriptyline in Depression 4		LEVOPRAID 50 Achieves Higher Clinical Response Than Mianserin 5
Results: LEVOPRAID 50 showed antidepressant activity comparable to Amitriptyline but its onset of effects was faster.		No.of Patients: 41(21 on Levosulpiride and 20 on Mianserin) suffering from major depression or dysthymia. Duration of Treatment: 60 days. Dose: Levosulpiride 200-300 mg/day, Mianserin 90-120 mg/day

Safety Profile:
Teh safety of Levosulpiride (LEVOPRAID 50 tablet bid) was assessed in 2145 patients with depressive disorders, over a period of 2-3 months at 60 Psychiatric centres all over italy.

		Download